|
2024
|
Invention
|
Prophylactic drug/therapeutic drug for progressive supranuclear palsy. Provided is a novel prophy... |
|
|
Invention
|
Antibody-drug conjugate containing anti-cd138 antibody. Provided is an antibody-drug conjugate (A... |
|
|
Invention
|
Ftd-tpi combination preparation, pd-1 pathway antagonist, and combination use of vegf pathway ant... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treat... |
|
|
Invention
|
Combination therapy using azabicyclo compound for cancer.
Provided is a novel method for treatin... |
|
|
Invention
|
Method for treating cancer patients with severe renal impairment.
A method for treating cancer i... |
|
2023
|
Invention
|
Crystals of acetate hydrochloride. The present invention provides I form crystals of 4-piperidiny... |
|
|
Invention
|
Selective inhibitor of exon 20 insertion mutant egfr.
An antitumor agent comprising a compound s... |
|
|
Invention
|
5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one and crystal of salt thereof. Provided is a type-I crystal of... |
|
|
Invention
|
Analogues of azabicyclic compounds. Provided are novel compounds which are analogues to be remove... |
|
|
Invention
|
Pharmaceutical composition containing pimitespib. Provided is a pharmaceutical composition contai... |
|
|
Invention
|
Combination decitabine and cedazuridine solid oral dosage forms. 2 administered as a one hour (1 ... |
|
|
G/S
|
Advertising and publicity services; business management analysis and business consultancy; busine... |
|
|
Invention
|
Crystal of 7h-pyrrolo[2,3-d]pyrimidine-4-amine derivative. Provided is a crystal of a compound ha... |
|
|
Invention
|
Method for producing 7h-pyrrolo[2,3-d]pyrimidine-4-amine derivative. 11 in formula (II) under bas... |
|
|
Invention
|
Prophylactic or therapeutic agent, for lung inflammation and fibrosis, containing compound having... |
|
|
Invention
|
Ph-dependent anti-sulfated glycosaminoglycan antibody and antibody-drug conjugate. Provided is an... |
|
|
Invention
|
Stabilized formulation for fosnetupitant or pharmaceutically acceptable salt thereof, and a metho... |
|
|
Invention
|
Crystal form of cyclohexenone compound. The purpose of the present disclosure is to provide a cry... |
|
2022
|
Invention
|
Small molecule inhibitors of kras mutated proteins. Compounds of Formula (I) or their pharmaceuti... |
|
|
Invention
|
Process for preparing a benzoate salt of a 1-(3-aminopyrrolidine-1-carbonyl)-3,4-diphenylbenzene ... |
|
|
Invention
|
Treatment methods for subjects having cancer with a dysregulated mapk and/or pi3k pathway. A meth... |
|
|
Invention
|
Combinatory therapy for cancer using biphenyl compound and immune checkpoint molecule regulator. ... |
|
|
Invention
|
Anti-growth hormone antibody. In one embodiment, the present invention provides an antibody speci... |
|
|
Invention
|
New juniper pollen protein. The present disclosure relates to a juniper pollen protein selected f... |
|
|
Invention
|
Small molecule inhibitors of kras mutated proteins.
Compounds of Formula (I) or their pharmaceut... |
|
|
Invention
|
Treatment methods for subjects with cancer having an aberration in egfr and/or her2.
A method of... |
|
|
Invention
|
Solid forms of salts of 4-[5-[(3s)-3-aminopyrrolidine-1-carbonyl]-2-[2-fluoro-4-(2- hydroxy-2-eth... |
|
|
Invention
|
Treating cancer in patient with pten inactivating mutation.
A method of treating a subject with ... |
|
2021
|
Invention
|
Brain-migrating tumor therapeutic agent containing fused pyrimidine compound as active ingredient... |
|
|
Invention
|
Methods of using 4-amino-n-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholinoprop-... |
|
|
Invention
|
Methods of treating ribonucleotide reductase-related diseases with a ribonucleotide reductase inh... |
|
|
Invention
|
Treatment regimens for exon-20 insertion mutant egfr cancers.
Treatment regimens for exon 20 ins... |
|
|
Invention
|
Treating cancer in patient having co-occurring genetic alteration in fgfr2 and a cancer driver ge... |
|
|
Invention
|
Novel cycloalkenone compound or salt thereof.
Provided are a compound represented by formula (I)... |
|
|
Invention
|
Crystal of pyrimidine compound.
A crystal of 7-((3R,5S)-1-acryloyl-5-methylpyrrolidin-3-yl)-4-am... |
|
|
Invention
|
Egfr inhibitor.
Provided is a therapeutic agent for a disease associated with EGFR, the agent co... |
|
|
Invention
|
Pyrimidine compound-containing combination to be used in tumor treatment.
Provided is a tumor tr... |
|
|
Invention
|
Urinary symptom therapeutic agent.
The present invention addresses the problem of providing a vo... |
|
|
G/S
|
Application software; computer programs; electronic
machines, apparatus and their parts; smartph... |
|
|
G/S
|
Downloadable application software for processing images, graphics and text; downloadable computer... |
|
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations; dietary supplements for medical purposes; D... |
|
|
Invention
|
Anticancer combination therapy with n-(1-acryloyl-azetidin-3-yl)-2-((1h-indazol-3-yl)amino)methyl... |
|
|
Invention
|
Kras g12d protein inhibitors.
Compounds and pharmaceutically acceptable salts thereof inhibit th... |
|
|
G/S
|
Anti-cancer preparations; pharmaceutical preparations for the treatment of tumors; chemical reage... |
|
|
Invention
|
Cancer therapy using 3,5-disubstituted benzene alkynyl compound and mek inhibitor.
Provided is a... |
|
|
G/S
|
Anti-cancer preparations; pharmaceutical preparations for the treatment of tumor; chemical reagen... |
|
|
G/S
|
Anti-cancer preparations; pharmaceutical preparations for the treatment of tumors |
|
|
G/S
|
Breath freshening strips; breath freshening sprays; breath freshening preparations for personal h... |
|
|
G/S
|
Non-medicated hand soaps, body wash and laundry detergents; cosmetics; body sprays used as person... |
|
|
Invention
|
Combination decitabine and cedazuridine solid oral dosage forms.
Embodiments of the present inve... |
|
|
Invention
|
Process for producing acylthiourea compound.
The present invention relates to a process for prod... |
|
|
Invention
|
Treatment for chondrodystrophia.
A pharmaceutical composition for treating cartilage dysplasia, ... |
|
|
Invention
|
Enhancement of anti-tumor activity of shp2 inhibitor pyrimidinone in combination with novel cance... |
|
2020
|
G/S
|
Meteorological information; architectural design; surveying; geological research; geological surv... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for the trea... |
|
|
Invention
|
A compound having inhibitory activity against kras g12d mutation.
The present invention relates ... |
|
|
Invention
|
Polypeptide having mmp2-inhibitory effect.
The present invention provides a substituted polypept... |
|
|
Invention
|
Urea compound for antagonizing lpa1 receptor.
The present invention provides a compound represen... |
|
|
G/S
|
Pharmaceutical preparations; Preparations for use in the prevention and treatment of motion sickn... |
|
|
G/S
|
Pharmaceutical preparations for treating cancer; pharmaceutical preparations for treating immune ... |
|
2019
|
Invention
|
Pyrazolo[1,5-a]pyrimidine macrocyclic compound.
The present invention provides a novel compound ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of osteoarthritis; pharmaceutical preparations for ... |
|
|
G/S
|
Dentifrices; cosmetics; toilet waters; beauty serums; cosmetics, namely, foundation makeup; make-... |
|
|
G/S
|
Dentifrices; cosmetics; toilet waters; beauty serums;
cosmetics, namely, base makeup; make-up po... |
|
|
G/S
|
Laundry and bleaching preparations, namely, laundry detergent and laundry bleach; breath fresheni... |
|
|
G/S
|
Business consultancy relating to business management, sales, acquisitions and mergers; business r... |
|
|
G/S
|
Pharmaceutical preparations for human use, namely, for the treatment of diabetes |
|
|
G/S
|
Dietary supplements and liquid vitamin supplements containing honey and caffeine Non-alcoholic be... |
